Picture of China Resources Pharmaceutical logo

3320 China Resources Pharmaceutical Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousLarge CapContrarian

Annual cashflow statement for China Resources Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
R2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M
Source:ARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:
fx
Final
fx
Final
FinalFinal
fx
Preliminary
Net Income/Starting Line6,2946,9788,3619,880
Depreciation
Amortisation
Non-Cash Items3,5102,7602,7263,211
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-4,678-1,422-2,824-705
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities7,30010,65810,82115,550
Capital Expenditures-1,974-2,524-2,740-3,133
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-32.1-5,1041,9211,065
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-2,006-7,628-819-2,067
Financing Cash Flow Items-5,196-1,571-7,491-213
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-5,7062,494-9,126-4,065
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1,1715,2249089,427